Eli Lilly to Acquire Verve Therapeutics in $1.3 Billion Deal

Eli Lilly announced its acquisition of gene-editing startup Verve Therapeutics in a deal with up to a potential of $1.3 billion, expanding its pipeline, which now also features weight-loss medications and its blockbuster diabetes drugs...

Samsung Biologics Unveils Organoid Platform to Boost Drug Discovery

The launch of Samsung Organoids, which is a advanced drug screening services to support clients in drug discovery and development was announced by Samsung Biologics, a leading contract development and manufacturing organization

India Supplies 70% of WHO Vaccines, 14% of US Generic Imports

The Smt. Anupriya Patel, Union Minister of State for Health & Family Welfare and Chemicals & Fertilizers, provided a note to address at the Second Policymakers’ Forum, organized by the Indian Pharmacopoeia Commission

Roche's Prasinezumab Heads to Phase III for Early-Stage Parkinson's

Roche has reported it will move prsazinezumab, its investigational anti-alpha-synuclein antibody, into Phase III development for early-stage Parkinson’s disease following an assessment

FQPL Pharma Leaders' National Meet Set for June 21

The Forum for Quality Pharma Leaders (FQPL), will hold its national meeting on June 21 at the JSS College of Pharmacy at JSS Academy of Higher Education and Research (JSSAHER)...

Lupin signs deal with China's SUP for Tiotropium DPI rollout

Pharmaceutical company Lupin Ltd announced that it has entered into a licensing and supply agreement with China's Sino Universal Pharmaceuticals (SUP) for marketing Tiotropium dry...

Innovation on Display: London Biotechnology Show 2025 Returns in 2 days

In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science

DBT Invites Proposals for Green Biomanufacturing of APIs & Chemicals

Under its BioE3 (Biotechnology for Economy, Environment, and Employment) policy, which aims to promote high-performance biomanufacturing, the Department of Biotechnology (DBT) intends to support the biomanufacturing of active pharmaceutical

India's Pharma Sector Faces Heightened FDA Scrutiny on Quality

India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...

Gujarat to Host Global Pharma Delegation on June 18 in Ahmedabad

Gujarat will soon be able to share its strong pharmaceutical and healthcare ecosystem with the world through an international delegation from 41 countries on June 18, 2025. The visit is part of the 2nd...

© 2025 India Pharma Outlook. All Rights Reserved.